Quick Answer
Entera Bio Ltd. reported Operating Income Loss of -$11.53 million for the year ending 2025.
- Entera Bio Ltd. showed a decrease of -20.3% in Operating Income Loss from 2024 to 2025.
- This data is from Entera Bio Ltd.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), Entera Bio Ltd.'s Operating Income Loss has declined by 3.2%.
- Historical annual values: Fiscal year 2025: -$11.53 million | Fiscal year 2024: -$9.59 million | Fiscal year 2023: -$8.89 million | Fiscal year 2022: -$13.02 million | Fiscal year 2021: -$12.22 million | Fiscal year 2020: -$11.17 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: